The key question before us is simple: Whose interest should guide food policy in India? The credibility of India's food regulatory system depends on the answer to this question.
The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.
Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.
A study published 19 February in Cell Metabolism, a Cell Press journal, found red blood cells step in as a major 'glucose sink' when oxygen levels fall.
Researchers followed nearly 2,700 adults aged 45 to 55 over a decade, drawing data from two long-running cohort studies, find mismatch between healthier lifestyle and clinical risk.
Division bench of Delhi HC overturned 2019 order by single-judge bench, restoring ban on manufacture, sale, and distribution of triple-drug combinations for type 2 diabetes.
Studies reveal Antarctic ice crisis, brainless robots powered by air, the power of ‘desert cherries’ in fighting diabetes, and the link between gut microbes and heart disease.
Scientists associated with Madras Diabetes Research Foundation (MDRF) find that it often presents with more severe beta-cell dysfunction and relatively less insulin resistance.
Noel Tata’s intervention on the subject of Chandra’s extension in the February 2026 meeting was contrary to the unanimous stand taken by Tata Trusts in July 2025 on the matter.
The rules now take effect on 1 July instead of 1 April, the Reserve Bank of India said. New rules may raise cost of raising capital for proprietary trading firms & squeeze profits.
Oleksandr Yakovenko, founder of Ukrainian drone maker TAF Industries, further went on to highlight the growing 'irrelevance' of European defence platforms.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS